TLIS Logo

Talis Biomedical Corporation (TLIS) 

NASDAQ
Market Cap
$15.49M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
772 of 809
Rank in Industry
103 of 107

Largest Insider Buys in Sector

TLIS Stock Price History Chart

TLIS Stock Performance

About Talis Biomedical Corporation

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

Insider Activity of Talis Biomedical Corporation

Over the last 12 months, insiders at Talis Biomedical Corporation have bought $0 and sold $0 worth of Talis Biomedical Corporation stock.

On average, over the past 5 years, insiders at Talis Biomedical Corporation have bought $53.32M and sold $210,665 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 50,000 shares for transaction amount of $218,250 was made by BAKER BROS. ADVISORS LP () on 2021‑11‑18.

List of Insider Buy and Sell Transactions, Talis Biomedical Corporation

2021-11-18PurchaseBAKER BROS. ADVISORS LP
50,000
0.2117%
$4.37$218,250-77.36%
2021-08-13SaleRamakrishnan Ramesh
27,502
0.1055%
$7.66$210,665-71.83%
2021-05-17PurchaseScott Randal W.director
11,000
0.0426%
$10.11$111,210-51.03%
2021-05-14PurchaseScott Randal W.director
9,000
0.0354%
$10.16$91,440-47.52%
2021-02-17PurchaseBAKER BROS. ADVISORS LP
6.25M
31.505%
$16.00$100M-65.14%
2021-02-17PurchaseScott Randal W.director
312,500
1.5752%
$16.00$5M-65.14%
2021-02-17PurchasePopovits Kimberly Jdirector
5,300
0.0267%
$16.00$84,800-65.14%
2021-02-17PurchasePosard Matthew L.director
62,500
0.315%
$16.00$1M-65.14%
2021-02-17PurchaseLiu DouglasSr. Vice President, Operations
4,000
0.0202%
$16.00$64,000-65.14%
2021-02-17PurchaseFlick Karen E.Chief of Staff, Sr. VP, Legal
2,000
0.0101%
$16.00$32,000-65.14%
2021-02-17PurchaseMoody John Roger JrChief Financial Officer
1,700
0.0086%
$16.00$27,200-65.14%
2021-02-17PurchaseRamakrishnan RameshSr. Vice President, R&D
1,000
0.005%
$16.00$16,000-65.14%

Insider Historical Profitability

<0.0001%
BAKER BROS. ADVISORS LP
7053176
22.2619%
$8.5020<0.0001%
Popovits Kimberly Jdirector
215090
0.6789%
$8.5010<0.0001%
Posard Matthew L.director
62500
0.1973%
$8.5010<0.0001%
Ramakrishnan Ramesh
38619
0.1219%
$8.5011<0.0001%
Scott Randal W.director
20000
0.0631%
$8.5030<0.0001%
Liu DouglasSr. Vice President, Operations
4000
0.0126%
$8.5010<0.0001%
Flick Karen E.Chief of Staff, Sr. VP, Legal
2000
0.0063%
$8.5010<0.0001%
Moody John Roger JrChief Financial Officer
1700
0.0054%
$8.5010<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Baker Bros Advisors LP$4.45M27.9508,3230%+$00.06
Bml Capital Management Llc$374,001.002.3542,7430%+$00.29
The Vanguard Group$271,364.001.731,0130%+$0<0.0001
Susquehanna International Group$152,521.000.9617,431+11.95%+$16,274.97<0.0001
Prelude Capital$130,620.000.8214,9280%+$00.01
Geode Capital Management$104,077.000.6511,890+5.41%+$5,339.53<0.0001
Renaissance Technologies$90,000.000.5710,299New+$90,000.00<0.0001
BlackRock$41,221.000.264,711-54.84%-$50,058.45<0.0001
Tower Research Capital$8,111.000.05927-6.17%-$533.73<0.0001
Morgan Stanley$5,556.000.04635+71.16%+$2,309.90<0.0001
UBS$1,051.000.01120-5.51%-$61.31<0.0001
Advisor Group Holdings Inc$1,067.000.01122+16.19%+$148.68<0.0001
Wells Fargo$114.00<0.01130%+$0<0.0001
Larson Financial Group Llc$123.00<0.01140%+$0<0.0001
JPMorgan Chase$26.00<0.013+50%+$8.67<0.0001
Qube Research & Technologies$18.00<0.0120%+$0<0.0001